Lincoln National Corp’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,608	Closed	-$1.09M	–	1103
2024 Q1	$1.09M	Buy	2,608 +548	+27%	+$232K	0.02%	492
2023 Q4	$838K	Buy	2,060 +714	+53%	+$264K	0.01%	507
2023 Q3	$468K	Buy	1,346 +154	+13%	+$53.9K	0.01%	626
2023 Q2	$419K	Sell	1,192 -1,172	-50%	-$395K	0.01%	666
2023 Q1	$745K	Buy	2,364 +34	+1%	+$10.2K	0.02%	463
2022 Q4	$673K	Buy	2,330 +874	+60%	+$266K	0.02%	456
2022 Q3	$422K	Buy	1,456 +101	+7%	+$29.1K	0.01%	542
2022 Q2	$382K	Buy	1,355 +17	+1%	+$4.55K	0.01%	560
2022 Q1	$349K	Buy	1,338 +68	+5%	+$16.1K	0.01%	668
2021 Q4	$278K	Sell	1,270 -1	-0.1%	-$194	0.01%	737
2021 Q3	$231K	Buy	1,271 +246	+24%	+$48K	0.01%	782
2021 Q2	$206K	Buy	+1,025	New	+$214K	﹤0.01%	803